Though not yet approved for overweight or obesity, Mounjaros manufacturer Eli Lilly is seeking FDA approval for weight management due to the drugs remarkable effects on weight loss
This dose escalation drug has been extensively studied as a treatment strategy for managing obesity in individuals who do not have type 2 diabetes
This includes areas like the insula, amygdala, and orbitofrontal cortex
The safest supplement plan starts with known gaps, not a generic cart of pills
Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan
Mycotoxin-producing Fusarium is most affected by ozonation